James R. Bonham

451 total citations
20 papers, 302 citations indexed

About

James R. Bonham is a scholar working on Clinical Biochemistry, Molecular Biology and Genetics. According to data from OpenAlex, James R. Bonham has authored 20 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 9 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in James R. Bonham's work include Metabolism and Genetic Disorders (13 papers), Biochemical and Molecular Research (4 papers) and Genomics and Rare Diseases (3 papers). James R. Bonham is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Biochemical and Molecular Research (4 papers) and Genomics and Rare Diseases (3 papers). James R. Bonham collaborates with scholars based in United Kingdom, United States and Sweden. James R. Bonham's co-authors include S. E. Olpin, Mark Sharrard, M. Downing, N. J. Manning, R. J. Pollitt, Emile Van Schaftingen, Jaak Jaeken, Gert Matthijs, Younès Achouri and Elsa Wiame and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Human Genetics and The Journal of Pediatrics.

In The Last Decade

James R. Bonham

18 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Bonham United Kingdom 9 180 171 70 44 42 20 302
Boris Gebhardt Germany 10 176 1.0× 219 1.3× 36 0.5× 64 1.5× 28 0.7× 12 422
Cynthia Le Mons United States 5 217 1.2× 131 0.8× 94 1.3× 44 1.0× 36 0.9× 9 270
Tanyel Zübarioğlu Türkiye 10 121 0.7× 108 0.6× 43 0.6× 56 1.3× 49 1.2× 52 281
Mary Anne D. Chiong Philippines 10 142 0.8× 168 1.0× 26 0.4× 54 1.2× 36 0.9× 31 295
Satoko Hirano Japan 10 149 0.8× 222 1.3× 17 0.2× 32 0.7× 37 0.9× 19 358
Andrea Schlune Germany 11 218 1.2× 157 0.9× 89 1.3× 51 1.2× 44 1.0× 24 319
Vladimı́r Bzdúch Slovakia 8 65 0.4× 103 0.6× 41 0.6× 83 1.9× 39 0.9× 28 259
Mike Champion United Kingdom 6 198 1.1× 191 1.1× 24 0.3× 58 1.3× 55 1.3× 6 357
J. Bardet France 4 266 1.5× 193 1.1× 23 0.3× 32 0.7× 39 0.9× 5 314
Juan Bernar United States 11 109 0.6× 114 0.7× 98 1.4× 50 1.1× 89 2.1× 14 354

Countries citing papers authored by James R. Bonham

Since Specialization
Citations

This map shows the geographic impact of James R. Bonham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Bonham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Bonham more than expected).

Fields of papers citing papers by James R. Bonham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Bonham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Bonham. The network helps show where James R. Bonham may publish in the future.

Co-authorship network of co-authors of James R. Bonham

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Bonham. A scholar is included among the top collaborators of James R. Bonham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Bonham. James R. Bonham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schielen, Peter C. J. I., Rolf Zetterström, Maurizio Scarpa, et al.. (2025). International Survey on Phenylketonuria Newborn Screening. International Journal of Neonatal Screening. 11(1). 18–18.
2.
Webster, Dianne, Amy Gaviglio, Aysha Habib Khan, et al.. (2025). ISNS General Guidelines for Neonatal Bloodspot Screening 2025. International Journal of Neonatal Screening. 11(2). 45–45. 1 indexed citations
3.
Chudleigh, Jane, et al.. (2024). Parents' and childrens’ views of wider genomic testing when used as part of newborn screening to identify cystic fibrosis. SHILAP Revista de lepidopterología. 6. 100455–100455. 2 indexed citations
4.
Clark, C. C., et al.. (2024). International Perspectives of Extended Genetic Sequencing When Used as Part of Newborn Screening to Identify Cystic Fibrosis. International Journal of Neonatal Screening. 10(2). 31–31. 5 indexed citations
5.
Clark, C. C., et al.. (2024). Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England. International Journal of Neonatal Screening. 10(1). 13–13. 3 indexed citations
6.
Coillie, Samya Van, James R. Bonham, Fabian Hauck, et al.. (2024). Newborn Screening Today and Tomorrow: A Brief Report from the International Primary Immunodeficiencies Congress. International Journal of Neonatal Screening. 10(2). 30–30. 2 indexed citations
7.
Carling, Rachel S., Anupam Chakrapani, Patricia Hall, et al.. (2024). Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK. International Journal of Neonatal Screening. 10(1). 24–24.
8.
Garbade, Sven F., Claus‐Dieter Langhans, Georg F. Hoffmann, et al.. (2008). Qualitative urinary organic acid analysis: Methodological approaches and performance. Journal of Inherited Metabolic Disease. 31(6). 690–696. 13 indexed citations
9.
Race, Valérie, Younès Achouri, Elsa Wiame, et al.. (2007). Phosphoserine Aminotransferase Deficiency: A Novel Disorder of the Serine Biosynthesis Pathway. The American Journal of Human Genetics. 80(5). 931–937. 89 indexed citations
10.
11.
Olpin, S. E., Brage Storstein Andresen, Claus Bischoff, et al.. (2004). Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. Journal of Inherited Metabolic Disease. 28(4). 533–544. 54 indexed citations
12.
Johnson, Trevor N., Amin Rostami‐Hodjegan, Anupam Chakrapani, et al.. (2002). An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. British Journal of Clinical Pharmacology. 54(2). 140–146. 22 indexed citations
13.
O’Grady, Shane, et al.. (2001). Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.. PubMed. 27(3). 21–4. 5 indexed citations
14.
Bonham, James R., Philip A. I. Guthrie, M. Downing, et al.. (1999). The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. Journal of Inherited Metabolic Disease. 22(2). 174–184. 26 indexed citations
15.
Manning, N. J., James R. Bonham, M. Downing, et al.. (1999). Normal acylcarnitines in maternal urine during a pregnancy affected by glutaric aciduria type II. Journal of Inherited Metabolic Disease. 22(1). 88–89. 7 indexed citations
16.
Olpin, S. E., James R. Bonham, M. Downing, et al.. (1997). Carnitine‐acylcarnitine translocase deficiency ‐ a mild phenotype. Journal of Inherited Metabolic Disease. 20(5). 714–715. 29 indexed citations
17.
Bonham, James R.. (1996). Book review. Journal of Inherited Metabolic Disease. 19(1). 24–24. 2 indexed citations
18.
Bonham, James R.. (1993). The Investigation of Hypoglycaemia during Childhood. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 30(3). 238–247. 14 indexed citations
19.
Bonham, James R., et al.. (1992). Complete recovery from hemorrhagic shock and encephalopathy. The Journal of Pediatrics. 120(3). 440–443. 8 indexed citations
20.
Carpenter, Kevin, James R. Bonham, & Angus Clarke. (1990). Rett's syndrome and ornithine carbamoyltransferase deficiency. Journal of Inherited Metabolic Disease. 13(3). 308–310. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boris Gebhardt Breakdown of academic impact, for papers by Cynthia Le Mons Breakdown of academic impact, for papers by Tanyel Zübarioğlu Breakdown of academic impact, for papers by Mary Anne D. Chiong Breakdown of academic impact, for papers by Satoko Hirano Breakdown of academic impact, for papers by Andrea Schlune Breakdown of academic impact, for papers by Vladimı́r Bzdúch Breakdown of academic impact, for papers by Mike Champion Breakdown of academic impact, for papers by J. Bardet Breakdown of academic impact, for papers by Juan Bernar
Rankless by CCL
2026